Sunday, Oct 25
Turkish university begins final trials of coronavirus vaccine

Turkish university begins final trials of coronavirus vaccine

China launched a vaccine emergency use program in July, offering three experimental shots developed by a unit of Sinopharm and US-listed Sinovac Biotech.
16.09.2020 - 16:20

Turkey began final Phase 3 trials of an experimental Chinese coronavirus vaccine on Wednesday.

RESULTS WILL BE SENT TO WHO

According to the official sources, the first volunteers, a group of health care workers, were vaccinated at Hacettepe University Faculty of Medicine.

The vaccine will be administered to between 1,200-1,300 health workers over 10 days and a second dose will be given 14 days after the first. The results of the trial will be sent the World Health Organization (WHO).

Turkish university begins final trials of coronavirus vaccine WATCH

The vaccine candidate will later be administered to volunteers with chronic diseases, with the aim of vaccinating 13,000 people.

Health Minister Fahrettin Koca is due to hold a news conference later in the day.

Koca announced last week that Phase 3 work had started on the Chinese vaccine candidate, as well as another developed by Pfizer. Russia’s application to conduct Phase 3 trials in Turkey for its experimental vaccine was being evaluated and a decision would likely be made this week, he said.